Steve Morin, PhD

Professor Emeritus

Honors and Awards
  • National Leadership Recognition Award, National AIDS Memorial Grove, 2009
  • Walter Gray Endowed Chair in HIV Science, UCSF AIDS Research Institute, 2009
  • Distinguished Senior Psychologist Award, American Psychological Association National Multicultural Conference and Summit, 2007
  • Stephen F. Morin Vanguard Award, California State University San Bernardino GLBT Students Association, 2004
  • Excellence in Abstract Submission among All Presenters, American Public Health Association, HIV/AIDS Section, 2003
  • Lifetime Achievement Award, Gay and Lesbian Medical Association, 2003
  • Distinguished Service Award, Society for the Psychological Study of Lesbian, Gay and Bisexual Issues, A Division of the American Psychological Association, 2002
  • Stephen F. Morin Day, in recognition of outstanding achievement on behalf of AIDS policy, Proclamation from the Mayor of San Francisco, 1998
  • Distinguished Contribution Award, Project Inform, San Francisco, 1998
  • Distinguished Humanitarian Award, American Association of Applied and Preventive Psychology, 1994
  • Distinguished Contribution to AIDS-Affected Communities, Gay and Lesbian Historical Society of Northern California, 1994
  • Distinguished Contribution to Psychology, California Psychological Association, 1989
  • Distinguished Professional Contribution to Public Service, American Psychological Association, 1988
  • Silver Psi Award for Meritorious Contribution, California Psychological Association, 1987
  • Distinguished Contribution Award, Committee on Lesbian and Gay Concerns, American Psychological Association, 1986
  • Distinguished Contribution Award, Society for the Psychological Study of Lesbian and Gay Issues: A Division of the APA, 1986
  • Fellow, American Psychological Association, 1982
Publications
  1. A Remarkable Legacy: The Wayne F. Placek Fund Grant Program.
  2. Global Health Diplomacy, Monitoring & Evaluation, and the Importance of Quality Assurance & Control: Findings from NIMH Project Accept (HPTN 043): A Phase III Randomized Controlled Trial of Community Mobilization, Mobile Testing, Same-Day Results, and Pos
  3. Implementing Multi-Level Interventions to Improve HIV Testing, Linkage-to-and Retention-in-Care Interventions.
  4. The Future of the Ryan White HIV/AIDS Program.
  5. Acceptance of the use of HIV surveillance data for care engagement: national and local community perspectives.
  6. Examining clinic-based and public health approaches to ascertainment of HIV care status.
  7. Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial.
  8. California's "Bridge to Reform": identifying challenges and defining strategies for providers and policymakers implementing the Affordable Care Act in low-income HIV/AIDS care and treatment settings.
  9. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).
  10. Understanding and addressing socio-cultural barriers to medical male circumcision in traditionally non-circumcising rural communities in sub-Saharan Africa.
  11. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation.
  12. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection.
  13. No "magic bullet": exploring community mobilization strategies used in a multi-site community based randomized controlled trial: Project Accept (HPTN 043).
  14. Health diplomacy and the adaptation of global health interventions to local needs in sub-Saharan Africa and Thailand: evaluating findings from Project Accept (HPTN 043).
  15. Socio-economic status and health care utilization in rural Zimbabwe: findings from Project Accept (HPTN 043).
  16. Understanding patient acceptance and refusal of HIV testing in the emergency department.
  17. Responding to the National HIV/AIDS Strategy-setting the research agenda.
  18. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study.
  19. A comparative evaluation of the process of developing and implementing an emergency department HIV testing program.
  20. Recent HIV type 1 infection among participants in a same-day mobile testing pilot study in Zimbabwe.
  21. Relationships over time between mental health symptoms and transmission risk among persons living with HIV.
  22. Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: The NIMH Multisite Acute HIV Infection Study: II.
  23. Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV.
  24. Behavior change following diagnosis with acute/early HIV infection-a move to serosorting with other HIV-infected individuals. The NIMH Multisite Acute HIV Infection Study: III.
  25. Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V.
  26. Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I.
  27. Influence of coping, social support, and depression on subjective health status among HIV-positive adults with different sexual identities.
  28. Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand.
  29. Disparities in reported reasons for not initiating or stopping antiretroviral treatment among a diverse sample of persons living with HIV.
  30. Internalized heterosexism among HIV-positive, gay-identified men: implications for HIV prevention and care.
  31. Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy.
  32. Randomized controlled trial of a cognitive-behavioral intervention for HIV-positive persons: an investigation of treatment effects on psychosocial adjustment.
  33. Receipt of prevention services among HIV-infected men who have sex with men.
  34. Predictors of attrition among high risk HIV-infected participants enrolled in a multi-site prevention trial.
  35. Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe.
  36. Building community partnerships: case studies of Community Advisory Boards at research sites in Peru, Zimbabwe, and Thailand.
  37. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study.
  38. Targeting HIV clinical training with maps: lessons from the Pacific AIDS Education and Training Center.
  39. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES).
  40. Correlates of suicidal ideation among HIV-positive persons.
  41. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: challenges and lessons learned.
  42. 'Healthcare is not something you can isolate from life in general": factors influencing successful clinical capacity building in the Pacific.
  43. Medication adherence and sexual risk behavior among HIV-infected adults: implications for transmission of resistant virus.
  44. A Social Problem-Solving Model of Adherence to HIV Medications.
  45. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model.
  46. Surface modification of indium tin oxide via electrochemical reduction of aryldiazonium cations.
  47. Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe.
  48. Provider fatalism reduces the likelihood of HIV-prevention counseling in primary care settings.
  49. HIV surveillance in theory and practice: assessing the acceptability of California's non-name HIV surveillance regulations.
  50. Electrochemical oxidation of catecholamines and catechols at carbon nanotube electrodes.
  51. Martin Rochlin (1928-2003).
  52. Policy perspectives on public health for Mexican migrants in California.
  53. Written clinic procedures enhance delivery of HIV "prevention with positives" counseling in primary health care settings.
  54. Missed opportunities: prevention with HIV-infected patients in clinical care settings.
  55. Why HIV infections have increased among men who have sex with men and what to do about it: findings from California focus groups.
  56. Community consultation in HIV prevention research: a study of community advisory boards at 6 research sites.
  57. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.
  58. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature.
  59. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies.